Martiniz-Garcia et al extended the FACED score for predicting high risk of exacerbation in a patient with bronchiectasis. The authors are from multiple institutions in Span and South America.
Patient selection: bronchiectasis
Difference from FACED score: addition of exacerbations in past year
Parameters:
(1) number of severe exacerbations in the past year (E)
(1) age of the patient in years (A)
(2) FEV1 as percent of predicted (F)
(3) dyspnea on the mMRC scale (D)
(4) number of lobes affected (extent, E)
(5) chronic colonization with Pseudomonas aeruginosa (C)
Parameter
Finding
Points
number of severe exacerbations
0
0
>= 1
2
age of the patient
< 70 years
0
>= 70 years
2
FEV1
>= 50% of predicted
0
< 50% of predicted
2
dyspnea on mMRC scale
0, I, II
0
III or IV
1
number of lobes affected
1 or 2
0
>= 3
1
colonization with Pseudomonas
absent
0
present
1
total score =
= SUM(points for all of the parameters)
Interpretation:
• minimum score: 0
• maximum score: 9
Total Score
Risk
5-Year Survival
0 to 3
low
96%
4 to 6
moderate
75%
7 to 9
high
44%
Performance:
• The area under the ROC curve is 0.87.
To read more or access our algorithms and calculators, please log in or register.
